Erika Hamilton, Chief Development Officer, Late Phase and Director, Breast Cancer Research Program at Sarah Cannon Research Institute, shared European Society for Medical Oncology (ESMO)’s post on X, adding:
“Honored to be among this group of ESMO Ambassadors!
Will be great science and updates coming out of ESMO26, follow us for recaps and highlights!”
Quoting ESMO’s post:
“ESMO is pleased to announce the ESMO Ambassadors for ESMO26.
They will share scientific highlights, expert perspectives and insights on the latest research presented at ESMO26 across tumor types and disciplines.
Other articles about Erika Hamilton on OncoDaily.